[go: up one dir, main page]

MX2008007897A - Metodos para administrar transdermicamente un agonista de receptor de indol serotonina y composiciones transdermicas para uso con los mismos. - Google Patents

Metodos para administrar transdermicamente un agonista de receptor de indol serotonina y composiciones transdermicas para uso con los mismos.

Info

Publication number
MX2008007897A
MX2008007897A MX2008007897A MX2008007897A MX2008007897A MX 2008007897 A MX2008007897 A MX 2008007897A MX 2008007897 A MX2008007897 A MX 2008007897A MX 2008007897 A MX2008007897 A MX 2008007897A MX 2008007897 A MX2008007897 A MX 2008007897A
Authority
MX
Mexico
Prior art keywords
serotonin receptor
methods
receptor agonist
indole serotonin
same
Prior art date
Application number
MX2008007897A
Other languages
English (en)
Inventor
Kunio Yoneto
Katsuyuki Inoo
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of MX2008007897A publication Critical patent/MX2008007897A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan métodos para suministrar transdérmicamente una cantidad terapéutica de un agonista de receptor de indol serotonina a un individuo en necesidad del mismo, por ejemplo, para proporcionar un nivel terapéutico de un agonista de receptor de indol de serotonina a un individuo que lo requiera; también se proporcionan formulaciones transdérmicas de agonistas receptores de indol serotonina que encuentran uso en la práctica de los métodos.
MX2008007897A 2005-12-20 2006-11-17 Metodos para administrar transdermicamente un agonista de receptor de indol serotonina y composiciones transdermicas para uso con los mismos. MX2008007897A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75276705P 2005-12-20 2005-12-20
US79045106P 2006-04-06 2006-04-06
PCT/US2006/061049 WO2007094876A2 (en) 2005-12-20 2006-11-17 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same

Publications (1)

Publication Number Publication Date
MX2008007897A true MX2008007897A (es) 2009-03-04

Family

ID=38371959

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008007897A MX2008007897A (es) 2005-12-20 2006-11-17 Metodos para administrar transdermicamente un agonista de receptor de indol serotonina y composiciones transdermicas para uso con los mismos.

Country Status (13)

Country Link
US (2) US7816394B2 (es)
EP (1) EP1962837A4 (es)
JP (2) JP5225100B2 (es)
KR (1) KR20080077998A (es)
AR (1) AR056839A1 (es)
AU (2) AU2006338165B2 (es)
BR (1) BRPI0620216A2 (es)
CA (1) CA2633588A1 (es)
EA (1) EA200801369A1 (es)
IL (1) IL192074A0 (es)
MX (1) MX2008007897A (es)
TW (1) TW200738288A (es)
WO (1) WO2007094876A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100209484A1 (en) * 2009-02-13 2010-08-19 Hoo-Kyun Choi Transdermal Triptan Delivery System
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
US9557878B2 (en) * 2012-04-25 2017-01-31 International Business Machines Corporation Permitting participant configurable view selection within a screen sharing session
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
JP6002055B2 (ja) * 2013-02-13 2016-10-05 久光製薬株式会社 貼付剤
JP6151935B2 (ja) * 2013-03-11 2017-06-21 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP6216151B2 (ja) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 親水性薬物のエマルジョンパッチ
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
TWI857957B (zh) 2018-06-19 2024-10-11 德商Ｕｃｂ製藥有限公司 吡啶基及吡基-（氮）吲哚磺醯胺
EP3584244A1 (en) 2018-06-20 2019-12-25 UCB Pharma GmbH Substituted alkoxypyridinyl indolsulfonamides
JP7631235B2 (ja) 2019-06-17 2025-02-18 ウーツェーベー ファルマ ゲーエムベーハー 多発性硬化症のようなｃｎｓ障害を治療するためのｇｐｒ１７モジュレーターとしてのｎ‐（フェニル）‐インドール‐３‐スルホンアミド誘導体及び関連化合物
IL297861A (en) 2020-05-08 2023-01-01 Psilera Inc Novel compositions of matter and pharmaceutical compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807571A (en) 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
DE4314976C1 (de) * 1993-05-06 1994-10-06 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH08319234A (ja) * 1995-05-24 1996-12-03 Yuutoku Yakuhin Kogyo Kk 経皮吸収型消炎鎮痛貼付剤
DE19738855C2 (de) 1997-09-05 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
US6955819B2 (en) 1998-09-29 2005-10-18 Zars, Inc. Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
US20050042271A1 (en) * 1999-11-19 2005-02-24 Xel Herbaceuticals, Inc . Transdermal delivery system for alkaloids of aconitum species
DE19959913A1 (de) * 1999-12-11 2001-06-28 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
US6579878B1 (en) * 2000-07-07 2003-06-17 Targacept, Inc. Pharmaceutical compositions and methods for use
US6579898B2 (en) 2001-03-01 2003-06-17 Pfizer Inc. Compositions having improved bioavailability
ES2559666T3 (es) * 2001-03-07 2016-02-15 Hisamitsu Pharmaceutical Co., Inc. Parche adhesivo
DE60228294D1 (en) 2001-06-05 2008-09-25 Ronald Aung-Din Topische migränetherapie
JP2003129022A (ja) * 2001-08-10 2003-05-08 Kosumedei:Kk 皮膚用粘着テープ
JP4792193B2 (ja) 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
JP2004292379A (ja) * 2003-03-27 2004-10-21 Nichiban Co Ltd 貼付剤
US20040258740A1 (en) * 2003-04-10 2004-12-23 Nene Labs Transdermal delivery composition
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device

Also Published As

Publication number Publication date
WO2007094876A2 (en) 2007-08-23
CA2633588A1 (en) 2007-08-23
US8609134B2 (en) 2013-12-17
BRPI0620216A2 (pt) 2011-11-01
JP2009520830A (ja) 2009-05-28
AU2006338165B2 (en) 2010-10-28
WO2007094876A3 (en) 2008-10-16
EA200801369A1 (ru) 2009-02-27
EP1962837A2 (en) 2008-09-03
JP5225100B2 (ja) 2013-07-03
IL192074A0 (en) 2009-02-11
US7816394B2 (en) 2010-10-19
EP1962837A4 (en) 2011-12-14
AU2006338165A1 (en) 2007-08-23
JP2013063992A (ja) 2013-04-11
AU2010241230A1 (en) 2010-11-25
US20070140977A1 (en) 2007-06-21
US20110002967A1 (en) 2011-01-06
AR056839A1 (es) 2007-10-24
KR20080077998A (ko) 2008-08-26
TW200738288A (en) 2007-10-16

Similar Documents

Publication Publication Date Title
IL192074A0 (en) Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
ECSP10010684A (es) Agonistas mezclados, basados en gip para el tratamiento de trastornos metabólicos y obesidad.
MX2010013020A (es) Metodos y composiciones para trastornos del sueño y otros trastornos.
NO20074567L (no) Glucagonreseptorantagoniser, fremstilling og terapeutisk anvendelse
NO20081250L (no) Kombinasjon av hypnotisk middel med langtidsvirkning og hypnotisk middel med korttidsvirkning, samt terapeutisk anvendelse av samme
NO20066016L (no) Diamin beta2 adrenergiske receptoragonister
MX2009006304A (es) Nuevos compuestos de oxadiazol.
NO20070213L (no) Glucagon reseptorantagonister, fremstilling og terapeutiske anvendelser
MX2010002781A (es) Combinacion novedosa de angentes terapeuticos.
EA201290394A1 (ru) Морфолинотиазолы в качестве позитивных аллостерических модуляторов альфа 7
UA106775C2 (uk) Комбінація антагоніста мускаринового рецептора та агоніста бета-2 адренорецептора
BR112013030939A2 (pt) derivado de indazol e pirrolopiridina e uso farmacêutico do mesmo
MA32622B1 (fr) Derives de carbonate de quinuclidine et composition medicinale les comprenant
MY150823A (en) Alkaloid aminoester derivatives and medicinal composition thereof
PE20120791A1 (es) Composiciones y metodos para terapia prolongada con aminopiridinas
SI1957484T1 (sl) Antagonisti glukagonskega receptorja, priprava in terapevtske uporabe
MX2010001574A (es) Ligandos del receptor cannabinoide.
IN2014DN09571A (es)
EA202091356A1 (ru) A2a АНТАГОНИСТЫ КАК УСИЛИТЕЛИ КОГНИТИВНОЙ И МОТОРНОЙ ФУНКЦИЙ
PT2366396E (pt) Imagiologia de perfusão miocárdica utilizando agonistas do receptor de adenosina
DK1951659T3 (da) Glucagonreceptorantagonister, fremstilling og terapeutisk anvendelse heraf
MX2010005009A (es) Uso de compuestos inmunomoduladores para el tratamiento de trastornos asociados con disfunciones endoteliales.
ATE481384T1 (de) Isoindolderivate als ep4-rezeptoragonisten
ZA200805232B (en) Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
MX2008002272A (es) Compuestos de ciclopropilo y composiciones para suministrar agentes activos.

Legal Events

Date Code Title Description
HH Correction or change in general